Trazodone Cost in Virginia (2026): Cash Prices, Insurance, Medicaid, and Savings

Trazodone hydrochloride (sold historically under the brand name Desyrel, and briefly as an extended-release product called Oleptro, now discontinued as a branded product) is a serotonin antagonist and reuptake inhibitor (SARI) that the FDA approved for major depressive disorder. It is not FDA-approved for insomnia, though it is widely prescribed off-label at lower doses for that purpose. Because generic trazodone has been available for decades and multiple manufacturers produce it, it is one of the least expensive prescription drugs on the US market, in either the antidepressant or sleep-aid categories.

The useful question for a Virginia patient is usually not "what does trazodone cost" in the abstract, since generic trazodone is reliably cheap almost everywhere in the country. The more consequential question is which variables actually move the price for you: the strength prescribed, whether the claim is coded for depression or for insomnia, whether you are on Medicaid or a commercial plan, and whether you run the prescription through insurance at all. Those variables, not geography, explain most of the price difference a Virginia patient will actually experience.

What is established: generic trazodone tablets (50 mg, 100 mg, 150 mg, 300 mg) are inexpensive relative to almost every other prescription sleep or depression medication, trazodone is not a federally or Virginia-scheduled controlled substance, and Virginia Medicaid places prior authorization requirements on many prescriptions rather than covering everything on request. What is plausible but not verified here: the exact cash price at any specific Virginia pharmacy chain, the specific copay tier assigned by any named insurer, and the turnaround time for a given Medicaid prior authorization. Those figures change often, are set locally, and are not supported by the source material available for this article. Anyone relying on a specific number should confirm it directly with the pharmacy, insurer, or Virginia Department of Medical Assistance Services (DMAS) before assuming it is current.

What generic trazodone tends to cost, and why exact prices need direct confirmation

Generic trazodone is a low-cost, multi-source drug. That fact is well established and holds true across most US states, including Virginia. However, the specific cash price a person pays at a given pharmacy on a given day depends on the pharmacy's own cash pricing, whether a discount card is applied, the strength dispensed, and the quantity in the fill. This article does not have a verified, dated source for a specific dollar figure at a specific Virginia pharmacy chain, so any number presented as an exact, current price should be treated as unverified until you check it directly.

What can be said with more confidence:

• Standard tablet strengths (50 mg and 100 mg) are typically the least expensive because they are the most commonly dispensed and manufactured by the largest number of generic makers.
• Higher strengths (150 mg, 300 mg) are sometimes priced somewhat higher per tablet, since fewer manufacturers produce them, though this varies by pharmacy and is not something a national reference can state precisely.
• Discount coupon programs (GoodRx, SingleCare, RxSaver, and similar services) and cash-pay pharmacy models frequently beat both the pharmacy's uninsured retail price and, in some cases, an insurance copay. Whether that is true for you depends on your specific plan and pharmacy, and the discounted price shown by any of these services changes over time, so it should be checked at the time of fill, not assumed from an older printout.
• The FDA first approved trazodone hydrochloride for major depressive disorder in the early 1980s, and it has been available generically for decades since (FDA drug approval database). Long-standing generic competition is the underlying reason trazodone is inexpensive; that is a stable, structural fact rather than a volatile price quote.

If your prescriber writes for the discontinued branded extended-release formulation, or a pharmacy dispenses under a brand-name NDC rather than the generic, the price can be substantially higher than for standard generic trazodone HCl tablets. Confirming that your prescription and your dispensed product are both the generic immediate-release formulation is one of the more reliable ways to keep the cost low, regardless of which pharmacy or insurer is involved.

Does Virginia Medicaid cover trazodone?

Virginia Medicaid, administered through DMAS, generally requires prior authorization for many prescription drugs, and trazodone is one of the medications where PA status has applied in various formulary cycles. Because Medicaid preferred drug lists (PDLs) are updated periodically and Medicaid managed care organizations (MCOs) operating in Virginia can each apply somewhat different rules, a reader should not assume a specific approval turnaround time, a specific copay amount, or a specific documentation requirement without checking the current PDL or contacting the relevant MCO or DMAS pharmacy help desk directly.

What is reasonably well established:

• Trazodone for major depressive disorder is a mainstream, guideline-consistent indication, and Medicaid programs generally do not treat approval for that indication as unusual.
• Off-label use for insomnia is a different clinical situation. A prescriber documenting an off-label indication should expect more scrutiny or additional documentation than for an on-label depression diagnosis, since off-label prescribing is not automatically covered the same way as an FDA-approved use.
• Virginia's Medicaid expansion population (adults up to 138% of the federal poverty level) accesses prescription drug benefits through the same MCO structure as traditional Medicaid enrollees, though the specific MCO you are enrolled in determines your plan's exact PA rules.

Given how often PDLs and PA criteria change, any Virginia Medicaid patient or prescriber should verify current requirements directly with DMAS or the patient's specific MCO rather than relying on a description written at a single point in time.

How commercial insurance typically treats trazodone, and where it does not

Generic trazodone is the kind of drug that commercial insurers commonly place on their lowest generic cost-sharing tier, because it is inexpensive and has been on the market for a long time. That is a reasonable general expectation, but this article does not have a verified, dated source confirming the specific tier placement, prior authorization status, or copay amount for any individual Virginia insurer, and formularies change from year to year. Do not assume a specific insurer's tier or copay without checking that plan's current formulary document or member portal.

Verification checklist: what you can treat as stable versus what you must confirm before relying on it

Use this checklist to separate facts about trazodone that are unlikely to change soon from facts that are tied to a specific plan, pharmacy, or date and therefore need a fresh check before you rely on them.

Stable, federal or clinical facts (unlikely to change without a formal regulatory or guideline update):

• Trazodone hydrochloride is FDA-approved for major depressive disorder in adults; it is not FDA-approved for insomnia.
• Trazodone is not a federally scheduled controlled substance under the DEA's schedule system, and Virginia does not separately schedule it.
• Antidepressants, including trazodone, carry an FDA boxed warning about increased suicidal thinking and behavior in patients under 25; this applies to the drug class regardless of the reason it was prescribed. Verify current label language on the FDA's drug database if you need the exact wording.
• Compounded preparations made by state-licensed 503A pharmacies from an individual prescription are a legal, regulated category of pharmacy practice distinct from FDA-approved manufactured drug products; 503A pharmacies operate under state board of pharmacy oversight together with applicable USP compounding standards.

Date-sensitive, plan- or state-specific facts (recheck before you rely on them, and note the date you checked):

• The specific cash price of trazodone at any named Virginia pharmacy or pharmacy chain.
• The discount shown by any specific coupon or discount card platform for a given pharmacy.
• Whether Virginia Medicaid or a specific Medicaid MCO currently requires prior authorization for trazodone, and what documentation it asks for.
• Which tier a specific commercial insurer places generic trazodone on, and what the member's copay is under that plan year's formulary.
• Whether a given telehealth platform or prescriber is currently licensed to prescribe to a Virginia resident, and under what state telehealth rules.
• Whether a specific 503A compounding pharmacy in Virginia currently compounds trazodone and at what price, since compounding fees and formulation availability vary by pharmacy and are not centrally published.

If a number or rule in any article, including this one, is not dated to the day you are reading it, treat it as a starting point for a phone call to the pharmacy, insurer, or DMAS rather than a final answer.

Compounded trazodone in Virginia

Compounded preparations of trazodone (for example, a liquid suspension for a patient who cannot swallow tablets, or a custom low-dose preparation) can legally be prepared in Virginia by a state-licensed 503A compounding pharmacy from a valid prescription. This is a real and legitimate part of pharmacy practice, distinct from an FDA-approved manufactured product, and it exists mainly to serve patients with a specific clinical need that a standard commercial tablet does not meet, not as a routine substitute for an inexpensive generic tablet.

Compounded medications are generally more expensive than a standard generic tablet, and insurance coverage for compounded products is inconsistent; many commercial plans and Medicaid programs require documentation of medical necessity for a non-standard formulation before they will reimburse a 503A compound. If a compounded option is being considered mainly to save money rather than to address a genuine swallowing, dosing, or formulation problem, it is worth asking the pharmacy for a specific, current price and comparing it against a standard generic tablet plus a discount card, since the compounded route is not automatically cheaper.

Telehealth prescribing in Virginia

Virginia permits telehealth prescribing when a prescriber establishes a legitimate patient relationship, typically through a real-time audio-video encounter, consistent with the general framework the Virginia Board of Medicine and Board of Nursing apply to telehealth visits. Trazodone is not a controlled substance, so it does not carry the additional prescribing restrictions that apply to benzodiazepines or Z-drug hypnotics such as zolpidem.

Specific rules about which out-of-state clinicians may treat Virginia residents, refill duration limits, and required follow-up cadence are set by licensing boards and can be updated. A reader relying on telehealth access to trazodone should confirm current requirements with the prescriber's practice or the Virginia Board of Medicine rather than assuming a fixed rule holds indefinitely.

Clinical context: why trazodone is prescribed so often for sleep, and where the evidence is thinner than the prescribing pattern suggests

Trazodone's sedating effect at low doses, generally attributed to antagonism of serotonin 5-HT2A and histamine H1 receptors, is the pharmacological basis for its widespread off-label use in insomnia. It has become one of the most commonly prescribed medications for sleep complaints in the United States, despite lacking an FDA indication for that use.

The evidence supporting trazodone for insomnia is smaller in scale and older than the evidence base behind FDA-approved hypnotics. Clinical practice guideline groups that have reviewed pharmacologic treatments for chronic insomnia have not uniformly recommended trazodone as a preferred agent, citing limited high-quality trial evidence, even while acknowledging that clinicians prescribe it frequently, often because patients also have depression or anxiety that trazodone can address at the same time. Specific trial results, exact guideline wording, and any cost-comparison figures (for example, claims about system-wide savings from switching patients to trazodone) require verification against the current primary literature; the previous version of this page cited papers and a figure that could not be confirmed against the sources available here, so those specific numbers have been removed rather than repeated without support.

What can be said plainly: trazodone is inexpensive compared with FDA-approved hypnotics such as zolpidem, eszopiclone, suvorexant, or lemborexant, all of which typically cost substantially more at cash price. That price gap is a documented feature of how these drugs are marketed and priced as a class, separate from the open question of how their efficacy for insomnia compares head-to-head.

Common side effects include morning grogginess and orthostatic hypotension (a drop in blood pressure on standing, which raises fall risk, particularly in older adults). Priapism is a rare but serious risk that requires emergency care if an erection lasts more than four hours. Anyone starting trazodone, at any dose, should discuss these risks with the prescriber rather than relying on the low price as a proxy for a low side-effect burden.

Getting the lowest price without compromising the prescription

A few practical steps have reasonable support regardless of which Virginia pharmacy or plan you use:

• Ask the pharmacy for its cash price before running the prescription through insurance, especially on a high-deductible plan. For a drug this inexpensive, the uninsured cash price sometimes beats an insurance copay, but this needs to be checked at your specific pharmacy rather than assumed.
• Compare at least two discount card platforms, since negotiated rates differ by pharmacy and change over time.
• Confirm that the prescription and the dispensed product are both the generic immediate-release formulation, not a branded or extended-release version, since that is the single largest known driver of price difference for this drug.
• If you are on Medicaid, confirm current prior authorization requirements with your MCO or DMAS before assuming a prior year's rule still applies.
• If cost is a barrier, ask your prescriber or a local federally qualified health center about 340B pricing eligibility; specific per-fill prices under 340B are not something this article can state accurately, since they depend on the individual clinic and current program terms.

Frequently asked questions

Is trazodone a controlled substance in Virginia? No. Trazodone is not scheduled under federal DEA classification or Virginia law. It requires a prescription but does not carry the refill and prescribing restrictions that apply to Schedule II through V drugs such as benzodiazepines or zolpidem.

Does Virginia Medicaid cover trazodone? Virginia Medicaid can cover trazodone, but prior authorization requirements and documentation standards are set at the DMAS and MCO level and are updated periodically. Confirm current status with DMAS or your specific Medicaid MCO rather than relying on a fixed description.

Is compounded trazodone legal in Virginia? Yes. Licensed 503A compounding pharmacies in Virginia can legally prepare compounded trazodone from a valid prescription, under state board of pharmacy oversight and applicable compounding standards. Compounded products are generally more expensive than standard generic tablets and are not consistently covered by insurance.

Can trazodone be prescribed by telehealth in Virginia? Virginia generally permits telehealth prescribing when a prescriber establishes a legitimate patient relationship, and trazodone's non-controlled status makes this more straightforward than for scheduled sleep medications. Specific licensing and visit-frequency rules should be confirmed with the prescriber's practice or the Virginia Board of Medicine.

Why is trazodone so much cheaper than other sleep medications? Trazodone has been available as a multi-source generic for decades, which has driven down its price relative to newer, patent-protected hypnotics such as suvorexant or lemborexant. This is a structural feature of generic drug pricing rather than a reflection of relative effectiveness, which is a separate clinical question.

References

1. US Food and Drug Administration. Drugs@FDA and drug label database. https://www.accessdata.fda.gov/

Note on sources: earlier drafts of this article cited specific PubMed identifiers and a named researcher quotation that could not be verified against the primary literature available for this review. Those citations, the quotation, and the unverified precise cost and MCO-specific claims have been removed rather than repeated. Any reader who needs a specific study result, a named formulary rule, or a specific current price should verify it against DMAS, the relevant insurer's current formulary, or the pharmacy directly, since this article is not a substitute for that confirmation and has not yet undergone qualified medical review.